These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Combination of ziprasidone and clozapine in treatment-resistant schizophrenia. Zink M, Mase E, Dressing H. Hum Psychopharmacol; 2004 Jun; 19(4):271-3. PubMed ID: 15181656 [Abstract] [Full Text] [Related]
27. The influence of the CYP2D6 polymorphism on psychopathological and extrapyramidal symptoms in the patients on long-term antipsychotic treatment. Plesnicar BK, Zalar B, Breskvar K, Dolzan V. J Psychopharmacol; 2006 Nov; 20(6):829-33. PubMed ID: 16478753 [Abstract] [Full Text] [Related]
31. [Risperidone-induced tardive dystonia: a case of torticollis]. Fdhil H, Krebs MO, Bayle F, Vanelle JM, Olie JP. Encephale; 1998 Dec; 24(6):581-3. PubMed ID: 9949942 [Abstract] [Full Text] [Related]
32. Transient tardive dystonia: overview and case presentation. Seeman MV, Clodman D, Remington G. J Psychiatr Pract; 2008 Jul; 14(4):251-7. PubMed ID: 18664896 [Abstract] [Full Text] [Related]
33. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand. Wheeler AJ. Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732 [Abstract] [Full Text] [Related]
37. Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). Jones PB, Barnes TR, Davies L, Dunn G, Lloyd H, Hayhurst KP, Murray RM, Markwick A, Lewis SW. Arch Gen Psychiatry; 2006 Oct; 63(10):1079-87. PubMed ID: 17015810 [Abstract] [Full Text] [Related]